Suppr超能文献

肥厚型心肌病中南亚内含子缺失的再评估。

Reevaluation of the South Asian Intronic Deletion in Hypertrophic Cardiomyopathy.

机构信息

Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom (A.R.H., A.G., E.O., S.N., M.F., H.W., K.L.T.).

Division of Cardiovascular Medicine, John Radcliffe Hospital, Oxford, United Kingdom (A.R.H., A.G., E.O., S.N., M.F., H.W., K.L.T.).

出版信息

Circ Genom Precis Med. 2020 Jun;13(3):e002783. doi: 10.1161/CIRCGEN.119.002783. Epub 2020 Mar 12.

Abstract

BACKGROUND

The common intronic deletion, , detected in 4% to 8% of South Asian populations, is reported to be associated with cardiomyopathy, with ≈7-fold increased risk of disease in variant carriers. Here, we examine the contribution of to hypertrophic cardiomyopathy (HCM) in a large patient cohort.

METHODS

Sequence data from 2 HCM cohorts (n=5393) was analyzed to determine frequency and co-occurrence of pathogenic variants in HCM genes. Case-control and haplotype analyses were performed to compare variant frequencies and assess disease association. Analyses were also undertaken to investigate the pathogenicity of a candidate variant c.1224-52G>A.

RESULTS

Our data suggest that the risk of HCM, previously attributed to , can be explained by enrichment of a derived haplotype, , whereby a small subset of individuals bear both and a rare pathogenic variant, c.1224-52G>A. The intronic c.1224-52G>A variant, which is not routinely evaluated by gene panel or exome sequencing, was detected in ≈1% of our HCM cohort.

CONCLUSIONS

The c.1224-52G>A variant explains the disease risk previously associated with in the South Asian population and is one of the most frequent pathogenic variants in HCM in all populations; genotyping services should ensure coverage of this deep intronic mutation. Individuals carrying alone are not at increased risk of HCM, and this variant should not be tested in isolation; this is important for the large majority of the 100 million individuals of South Asian ancestry who carry and would previously have been declared at increased risk of HCM.

摘要

背景

在 4%至 8%的南亚人群中发现的常见内含子缺失 ,据报道与心肌病相关,变异携带者的患病风险增加约 7 倍。在这里,我们在一个大型患者队列中研究 对肥厚型心肌病(HCM)的贡献。

方法

分析了 2 个 HCM 队列(n=5393)的序列数据,以确定 在 HCM 基因中的频率和致病性变异的共发生。进行病例对照和单倍型分析,以比较变异频率并评估疾病相关性。还进行了分析,以研究候选变异 c.1224-52G>A 的致病性。

结果

我们的数据表明,先前归因于 的 HCM 风险可以通过衍生单倍型 的富集来解释,其中一小部分个体同时携带 和罕见的致病性变异 c.1224-52G>A。内含子 c.1224-52G>A 变异,其通常不由基因panel 或外显子组测序评估,在我们的 HCM 队列中约占 1%。

结论

c.1224-52G>A 变异解释了以前与南亚人群中 相关的疾病风险,是所有人群中 HCM 中最常见的致病性变异之一;基因分型服务应确保涵盖这种深内含子突变。单独携带 的个体患 HCM 的风险不会增加,不应单独检测该变异;对于携带 的 1 亿南亚裔个体中的绝大多数来说,这一点非常重要,他们以前被宣布为患 HCM 的风险增加。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验